echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Lancet Neurol: Blood Biomarkers for Alzheimer's Disease: Towards Clinical Application

    Lancet Neurol: Blood Biomarkers for Alzheimer's Disease: Towards Clinical Application

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    :copyright: This article comes from: Xiao Cui and his friends

    :copyright: This article comes from: Xiao Cui and his friends

     

     

     

    guide

    guide _

    read

    For many years, blood-based biomarkers for AD seemed out of reach, but recent results show that they can become a reality
    .


    How these biomarkers are brought into clinical practice will pave the way for blood biomarkers to support the development of diagnosis and treatment of AD and other dementias


    Part.


    Introduction of Blood Biomarkers of Sporadic AD Introduction of Blood Biomarkers of Sporadic AD Introduction of Blood Biomarkers of SporadicAD Protein (Aβ 1.


    Part.


    Blood Biomarkers for Hereditary Alzheimer's Disease Blood Biomarkers for Hereditary Alzheimer's Disease AD in rare cases has a single gene-determined etiology, namely mutations in the PSEN1, PSEN2, or APP genes, or the APP gene proliferation genes


    Part.


    Road to Clinical Implementation Road to ClinicalImplementation Clinical Assay Development and Validation (Phase II)


    Part.


    Summary and Outlook Summary and Outlook Due to the availability of ultrasensitive detection methods, blood biomarkers for the diagnosis and prognosis of AD are approaching clinical application


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.